Worth reading
48Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
60000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock-based compensation stock options (Series 6 stock acquisition rights)
発行・処分する株式数
60,000 common shares (600 stock acquisition rights, 100 shares per right)
Intended allottee
Category Directors of the company / Number of Employees 3 / Number of stock acquisition rights 75 stock acquisition rights, Category The Company's employees / Number of Employees 42 people / Number of stock acquisition rights 525 stock acquisition rights
No cash payment is required in exchange for the stock acquisition rights. The exercise price is ¥1 per share.
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥1 per share. There are no adjustment provisions.
Exercise period
Start Date 30 September 2027 / End date 29 September 2030
Number of Stock Acquisition Rights
Total number issued: 600. Outstanding unexercised rights: Not disclosed
Reason for acquisition without consideration
If approval or other authorization is obtained at a shareholders' meeting for a merger or other transaction in which the Company is the disappearing company, or if the holder of the stock acquisition rights becomes unable to exercise them before exercise under the exercise conditions.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Transfer restriction period
The rights may be exercised in stages during the exercise period from 30 September 2027 to 29 September 2030.
Conditions for lifting transfer restrictions
From 30 September 2027 to 29 September 2028, one-third of the number allotted may be exercised; from 30 September 2028 to 29 September 2029, two-thirds may be exercised; and from 30 September 2029 to 29 September 2030, all may be exercised. The holder must hold the position of director, audit & supervisory board member, executive officer or employee of the Company or one of its subsidiaries at the time of exercise, except where the Board of Directors determines that there is a valid reason.
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 3 / Number of allocated shares 7,500 shares (75 stock acquisition rights), Category The Company's employees / Number of Employees 42 people / Number of allocated shares 52,500 shares (525 stock acquisition rights)
Intended allottee's holding policy
The acquisition of the stock acquisition rights through transfer requires approval from the Company's Board of Directors.
Procedures under the Corporate Code of Conduct
Issuance resolved at a Board of Directors meeting held on 29 September 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock-based compensation stock options (Series 6 stock acquisition rights) |
| Number of shares to be issued or disposed of | 60,000 common shares (600 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | No cash payment is required in exchange for the stock acquisition rights. The exercise price is ¥1 per share. |
| Intended allottee | Category Directors of the company / Number of Employees 3 / Number of stock acquisition rights 75 stock acquisition rights, Category The Company's employees / Number of Employees 42 people / Number of stock acquisition rights 525 stock acquisition rights |
| Intended allottee's holding policy | The acquisition of the stock acquisition rights through transfer requires approval from the Company's Board of Directors. |
| Exercise price | The initial exercise price is ¥1 per share. There are no adjustment provisions. |
| Exercise period | Start Date 30 September 2027 / End date 29 September 2030 |
| Number of Stock Acquisition Rights | Total number issued: 600. Outstanding unexercised rights: Not disclosed |
| Transfer restriction period | The rights may be exercised in stages during the exercise period from 30 September 2027 to 29 September 2030. |
| Conditions for lifting transfer restrictions | From 30 September 2027 to 29 September 2028, one-third of the number allotted may be exercised; from 30 September 2028 to 29 September 2029, two-thirds may be exercised; and from 30 September 2029 to 29 September 2030, all may be exercised. The holder must hold the position of director, audit & supervisory board member, executive officer or employee of the Company or one of its subsidiaries at the time of exercise, except where the Board of Directors determines that there is a valid reason. |
| Reason for acquisition without consideration | If approval or other authorization is obtained at a shareholders' meeting for a merger or other transaction in which the Company is the disappearing company, or if the holder of the stock acquisition rights becomes unable to exercise them before exercise under the exercise conditions. |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 3 / Number of allocated shares 7,500 shares (75 stock acquisition rights), Category The Company's employees / Number of Employees 42 people / Number of allocated shares 52,500 shares (525 stock acquisition rights) |
| Procedures under the Corporate Code of Conduct | Issuance resolved at a Board of Directors meeting held on 29 September 2026 |
Items this document does not state (15)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesBasis for determining the amount to be paidTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further increase the motivation and morale of the Company's directors and employees to contribute to improving medium- to long-term performance and enhancing corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.